THERAPEUTIC APPROACH TO UREMIC PERICARDITIS

Authors

  • Lucas dos Anjos Seabra
  • Ryan Rafael Barros de Macedo
  • Yure Hermerson Pereira Lima
  • Patrícia Natsumi Figueiredo Dohara
  • Luis Alexandre Lago Marchesan
  • Giovanna Lopes Evangelista
  • Jose Wilson Alves de Menezes Filho
  • Tais Araújo Silva Alves Penha
  • Maria Angélica Bernardini Almeida de Oliveira
  • Cecília Varchavsky de Moraes
  • Uslaene Rocha de Lima
  • Eduardo da Silva Chaves

DOI:

https://doi.org/10.56238/isevmjv5n1-006

Keywords:

Uremic Pericarditis, Hemodialysis, Chronic Kidney Disease, Cardiac Tamponade, Uremic Toxins, Pericardial Inflammation

Abstract

Uremic pericarditis is an inflammatory condition affecting the pericardium in patients with severe renal dysfunction, particularly those with end-stage renal disease. Toxic metabolic byproducts accumulate in the bloodstream, triggering inflammation of this fibroelastic sac. Common clinical features include positional chest pain, a pericardial friction rub, and, in advanced cases, signs of cardiac tamponade. Uremic pericarditis is currently rare due to improved hemodialysis practices, but its decreasing frequency may contribute to delayed diagnosis. Early echocardiographic evaluation is essential in suspected cases to identify pericardial effusion or hemodynamic compromise. Although most patients improve with intensification of dialysis, some require surgical intervention, such as pericardiocentesis or the creation of a pericardial window, to relieve tamponade or obtain tissue for diagnostic purposes.

References

Adler, Y., Charron, P., Imazio, M., Badano, L., Barón-Esquivias, G., Bogaert, J., … Tomkowski, W. (2015). 2015 ESC guidelines for the diagnosis and management of pericardial diseases. European Heart Journal, 36(42), 2921–2964.

Badwan, O., et al. (2023). When should pharmacologic therapies be used for uremic pericarditis? Cleveland Clinic Journal of Medicine, 90(9), 549–554.

Emidio, F. C., et al. (2023). Tumor lysis syndrome rare presentation as uremic pericarditis: A case report. Cureus, 15(3), e35727.

European Society of Cardiology. (2015). Guidelines on the diagnosis and management of pericardial diseases. Oxford: ESC.

Imazio, M., & Adler, Y. (2013). Management of pericardial effusion. European Heart Journal, 34(16), 1186–1197.

Imazio, M., Brucato, A., Cemin, R., Ferrua, S., Maggiolini, S., Beqaraj, F., … Adler, Y. (2016). Colchicine for pericarditis: A systematic review and meta-analysis. Heart, 98(14), 1078–1082.

Nabalawi, R. A. (2025). Uremic pericarditis in a patient with hyperphosphatemic familial tumoral calcinosis: Case report. Case Reports in Medicine, 2025, 1–5.

Peride, I., et al. (2025). Understanding hemodialysis-associated pericarditis: Causes, symptoms, and management strategies. Journal of Clinical Medicine, 14(17), 5944.

Rhabneh, L., & Rout, P. (2025). Uremic pericarditis. In StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing.

Ribeiro, A. L. P., & Krieger, E. M. (2019). Complicações cardiovasculares na doença renal crônica. Revista Brasileira de Cardiologia, 32(4), 245–253.

Silva, B. M., et al. (2022). Acute pericarditis after COVID-19 in a peritoneal dialysis patient. CEN Case Reports, 11, 487–489.

Downloads

Published

2026-01-19

How to Cite

THERAPEUTIC APPROACH TO UREMIC PERICARDITIS. (2026). International Seven Journal of Multidisciplinary, 5(1), e9060. https://doi.org/10.56238/isevmjv5n1-006